Related Experiment Video
Updated: Jul 29, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Therapeutic Advances in the Treatment of Gastroesophageal Cancers
Jenny J Li1, Jane E Rogers2, Kohei Yamashita1,3
1Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Abstract:
Gastroesophageal cancers are a group of aggressive malignancies that are inherently heterogeneous with poor prognosis. Esophageal squamous cell carcinoma, esophageal adenocarcinoma, gastroesophageal junction adenocarcinoma, and gastric adenocarcinoma all have distinct underlying molecular biology, which can impact available targets and treatment response. Multimodality therapy is needed in the localized setting and treatment decisions require multidisciplinary discussions. Systemic therapies for treatment of advanced/metastatic disease should be biomarker-driven, when appropriate. Current FDA approved treatments include HER2-targeted therapy, immunotherapy, and chemotherapy. However, novel therapeutic targets are under development and future treatments will be personalized based on molecular profiling. Herein, we review the current treatment approaches and discuss promising advances in targeted therapies for gastroesophageal cancers.
Insights
Gastroesophageal cancers are aggressive and diverse. Treatment is evolving towards personalized, biomarker-driven therapies, including targeted treatments and immunotherapy, for better outcomes.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Gastroesophageal cancers encompass heterogeneous malignancies (esophageal squamous cell carcinoma, esophageal adenocarcinoma, gastroesophageal junction adenocarcinoma, gastric adenocarcinoma) with poor prognoses.
- These cancers exhibit distinct molecular biology, influencing treatment targets and response.
- Localized disease necessitates multimodality therapy and multidisciplinary decision-making.
Purpose of the Study:
- To review current treatment strategies for gastroesophageal cancers.
- To discuss emerging advances in targeted therapies and personalized medicine for these malignancies.
Main Methods:
- Review of current treatment approaches for gastroesophageal cancers.
- Discussion of promising advances in targeted therapies.
- Emphasis on biomarker-driven systemic therapies for advanced/metastatic disease.
Main Results:
- Current FDA-approved treatments include HER2-targeted therapy, immunotherapy, and chemotherapy.
- Novel therapeutic targets are under development, paving the way for personalized treatments.
- Molecular profiling is crucial for future treatment decisions.
Conclusions:
- Gastroesophageal cancers require tailored treatment strategies due to their heterogeneity.
- Biomarker-driven and personalized therapies, including targeted agents, represent the future of gastroesophageal cancer treatment.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

